InsiderSignal.AI

InsiderSignal.ai

ANIK - Anika Therapeutics, Inc.

Insider Purchase by Henneman John B III (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Henneman John B III, serving as Dir at Anika Therapeutics, Inc. (ANIK), purchased 5,000 shares at $14.66 per share, for a total transaction value of $73,320.00. Following this transaction, Henneman John B III now holds 54,871 shares of ANIK.

This purchase represents a 10.00% increase in Henneman John B III's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 1, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 4, 2026, 3 days after the trade was made.

Anika Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Henneman John B III

Dir

John B. Henneman III is a seasoned financial executive serving as a Director on the Board of Anika Therapeutics, Inc. (NASDAQ: ANIK) since September 2020.[[5]](https://ir.anika.com/John-B-Henneman)[[7]](https://www.sec.gov/Archives/edgar/data/898437/000114036126017488/ny20067128x1_def14a.htm) He currently holds the position of Lead Independent Director and is a member of the Governance and Nominating Committee, with his Class III directorship term expiring at the 2029 Annual Meeting.[[7]](https://www.sec.gov/Archives/edgar/data/898437/000114036126017488/ny20067128x1_def14a.htm) Henneman brings over 25 years of combined financial and operational experience, including roles as Chief Financial Officer at Integra LifeSciences Holdings Corp. and Executive Vice President and Chief Financial Officer at NewLink Genetics Corporation.[[5]](https://ir.anika.com/John-B-Henneman)[[7]](https://www.sec.gov/Archives/edgar/data/898437/000114036126017488/ny20067128x1_def14a.htm) His expertise spans executive leadership, industry experience, financing/accounting, and mergers & acquisitions.[[7]](https://www.sec.gov/Archives/edgar/data/898437/000114036126017488/ny20067128x1_def14a.htm) Recently, on May 1, 2026, he purchased 5,000 shares of ANIK at a weighted average price of $14.6639, increasing his direct holdings to 54,871 shares.[[1]](https://www.stocktitan.net/sec-filings/ANIK/form-4-anika-therapeutics-inc-insider-trading-activity-a8b5b4be0cfd.html)[[3]](https://whalewisdom.com/filing/henneman-john-b-iii-4-2026-05-04-083513-0400-anik)[[10]](https://fr.investing.com/news/insider-trading-news/john-henneman-administrateur-danika-therapeutics-achete-pour-73319-dactions-93CH-3392817) He serves as a director at multiple companies, including OFIX, with estimated insider holdings valued at $1.8M across three firms and a personal net worth of approximately $22.3M from reported shares.[[4]](https://insideraction.io/insider/0001187572)[[8]](https://www.gurufocus.com/insider/31642/henneman-john-b-iii)[[9]](https://www.benzinga.com/sec/insider-trades/0001187572/JOHN-HENNEMAN-III) Age 64 as of recent filings.[[7]](https://www.sec.gov/Archives/edgar/data/898437/000114036126017488/ny20067128x1_def14a.htm)

View full insider profile →

Trade Price

$14.66

Quantity

5,000

Total Value

$73,320.00

Shares Owned

54,871

Trade Date

Friday, May 1, 2026

4 days ago

SEC Filing Date

Monday, May 4, 2026

Filed 3 days after trade

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Discussion

Sign in to join the discussion.
Loading comments…
View news mentioning ANIK

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/6184654

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime